MyLymphomaTeam

Mantle cell lymphoma (MCL) is a rare form of non-Hodgkin lymphoma that affects about 1 in 200,000 people. It develops when B cells (white blood cells that help fight infection) in the mantle zone of lymph nodes begin growing out of control due to genetic changes. While MCL is typically considered an aggressive form of Show Full Answer

Mantle cell lymphoma (MCL) is a rare form of non-Hodgkin lymphoma that affects about 1 in 200,000 people. It develops when B cells (white blood cells that help fight infection) in the mantle zone of lymph nodes begin growing out of control due to genetic changes. While MCL is typically considered an aggressive form of lymphoma, some cases can be more indolent (slow-growing). Initially, cancer cells may grow slowly within the lymph nodes, though they can eventually multiply more rapidly and spread to other parts of the body like the liver, bone marrow, and gastrointestinal tract.

It's important to work closely with your healthcare team to determine the specific characteristics of your MCL and develop an appropriate treatment plan. Early diagnosis and proper classification of the disease type can help improve treatment outcomes.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Mantle Cell Lymphoma Stages: Are Most People Diagnosed at Stage 4?

Understanding Mantle Cell Lymphoma